Your browser doesn't support javascript.
loading
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
Tripolt, Norbert J; Kolesnik, Ewald; Pferschy, Peter N; Verheyen, Nicolas; Ablasser, Klemens; Sailer, Sandra; Alber, Hannes; Berger, Rudolf; Kaulfersch, Carl; Leitner, Katharina; Lichtenauer, Michael; Mader, Arthur; Moertl, Deddo; Oulhaj, Abderrahim; Reiter, Christian; Rieder, Thomas; Saely, Christoph H; Siller-Matula, Jolanta; Weidinger, Franz; Zechner, Peter M; von Lewinski, Dirk; Sourij, Harald.
Afiliação
  • Tripolt NJ; Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Diabetology, Graz, Austria.
  • Kolesnik E; Medical University of Graz, Department of Internal Medicine, Division of Cardiology, Graz, Austria.
  • Pferschy PN; Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Diabetology, Graz, Austria.
  • Verheyen N; Medical University of Graz, Department of Internal Medicine, Division of Cardiology, Graz, Austria.
  • Ablasser K; Medical University of Graz, Department of Internal Medicine, Division of Cardiology, Graz, Austria.
  • Sailer S; Medical University of Graz, Department of Internal Medicine, Division of Cardiology, Graz, Austria.
  • Alber H; Klinikum Klagenfurt, Department of Cardiology, Klagenfurt am Wörthersee, Austria.
  • Berger R; Hospital Eisenstadt, Department of Internal Medicine, Eisenstadt, Austria.
  • Kaulfersch C; Klinikum Klagenfurt, Department of Cardiology, Klagenfurt am Wörthersee, Austria.
  • Leitner K; Klinikum Klagenfurt, Department of Cardiology, Klagenfurt am Wörthersee, Austria.
  • Lichtenauer M; Paracelsus Medical University Salzburg, Department of Internal Medicine II, Division of Cardiology and Internal Intensive Care Medicine, Salzburg, Austria.
  • Mader A; Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
  • Moertl D; University Hospital St. Pölten, Department of Internal Medicine III, St.Pölten, St.Pölten, Austria.
  • Oulhaj A; College of Medicine and Health Sciences, United Arab Emirates University, P.O.Box 17666, Al-Ain, United Arab Emirates.
  • Reiter C; Kepleruniklinikum Linz, Department of Cardiology and Intensive Care Medicine, Linz, Austria.
  • Rieder T; Kardinal Schwarzenberg'sches Krankenhaus Schwarzach, Department of Medicine, Schwarzach, Austria.
  • Saely CH; Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
  • Siller-Matula J; Medical University of Vienna, Department of Cardiology, Vienna, Austria.
  • Weidinger F; Krankenanstalt Rudolfstiftung, 2(nd) Medical Department with Cardiology and Intensive Care Medicine, Vienna, Austria.
  • Zechner PM; Hospital Graz II Site West, Department of Cardiology and Intensive Care Medicine, Graz, Austria.
  • von Lewinski D; Medical University of Graz, Department of Internal Medicine, Division of Cardiology, Graz, Austria. Electronic address: dirk.von-lewinski@medunigraz.at.
  • Sourij H; Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Diabetology, Graz, Austria.
Am Heart J ; 221: 39-47, 2020 03.
Article em En | MEDLINE | ID: mdl-31901799

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria